V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190005882 | 190001208 | null | 74.8 | Palliative (P) | 2019-03-18 | 2019-04-07 | CHOP R - 21 days | N | N | CABOZANTINIB | 100912080 |
| 190005889 | 190001211 | null | null | null | null | 2018-07-30 | Trial Unspecified | null | null | CAPECITABINE + OXALIPLATIN | 100948952 |
| 190005895 | 190001214 | 1.58 | 76.5 | Adjuvant (A) | 2019-11-10 | 2019-11-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101653541 |
| 190005901 | 190001218 | 1.56 | 49 | Curative (C) | 2016-08-06 | 2016-08-10 | Cetuximab + Radiotherapy Maint | 02 | Y | OXALIPLATIN + MDG | 100509481 |
| 190005904 | 190001219 | null | null | null | null | 2016-07-27 | Carboplatin + Docetaxel | null | null | PACLITAXEL | 101311078 |
| 190005914 | 190001222 | 1.77 | 76.6 | null | 2015-09-09 | 2015-09-10 | Docetaxel 75mg/m2 (21 day) | N | N | CARBOPLATIN + RT | 100685406 |
| 190005924 | 190001225 | 1.71 | 59 | Neo-adjuvant (N) | 2017-01-11 | 2017-01-12 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | CETUXIMAB | 100599490 |
| 190005931 | 190001229 | 0 | 70 | Palliative (P) | 2018-01-04 | 2018-01-25 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 101266082 |
| 190005939 | 190001232 | 1.87 | 58 | Curative (C) | 2019-07-09 | 2019-07-13 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | CISPLATIN + GEMCITABINE | 101607237 |
| 190005945 | 190001234 | null | null | null | null | 2019-10-10 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101545951 |
| 190005950 | 190001237 | null | null | null | null | 2018-08-02 | Oxaliplatin + Raltitrexed | null | null | CAPECITABINE + OXALIPLATIN | 100366194 |
| 190005952 | 190001239 | null | null | null | null | 2016-08-13 | FEC | null | null | OCTREOTIDE | 101356199 |
| 190005958 | 190001242 | 1.78 | 77.4 | Curative (C) | 2016-03-10 | 2016-03-25 | CETUXIMAB + RT | 02 | N | TRIAL UNSPECIFIED | 101467949 |
| 190005960 | 190001243 | null | null | null | null | 2018-03-24 | Carboplatin 21day + Paclitaxel 7day | null | null | CARBOPLATIN + PACLITAXEL | 100001793 |
| 190005964 | 190001244 | null | null | null | null | 2017-05-16 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100869968 |
| 190005966 | 190001245 | 1.63 | 87.6 | Palliative (P) | 2019-05-15 | 2019-05-27 | OST Euramos 1 Closed Trial - Ai | N | N | CISPLATIN + ETOPOSIDE | 100883114 |
| 190005981 | 190001249 | 1.72 | null | Palliative (P) | 2016-04-02 | 2016-04-02 | GemCarbo Days 1+8 | 02 | N | CAPECITABINE | 100352031 |
| 190005985 | 190001251 | null | null | null | null | 2016-10-20 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 101847449 |
| 190005987 | 190001253 | null | null | null | null | 2016-01-22 | ECX | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100038159 |
| 190005997 | 190001256 | null | null | null | null | 2018-08-11 | Cisplatin + Etoposide po&iv 3 day | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100667578 |
| 190006001 | 190001258 | 1.68 | 89 | Palliative (P) | 2018-11-26 | 2018-11-26 | Cisplatin + Radiotherapy + CISPLATIN | 2 | N | CISPLATIN | 101574732 |
| 190006016 | 190001264 | null | null | null | null | 2019-04-22 | ECX | null | null | CISPLATIN + RT | 101627864 |
| 190006020 | 190001265 | null | null | null | null | 2019-08-15 | GEMCARBO | null | null | CAPECITABINE | 101635300 |
| 190006024 | 190001267 | 0 | 59.7 | Adjuvant (A) | 2016-09-14 | 2016-09-15 | Fluorouricil + Folonic Acid (MdG) | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101866119 |
| 190006027 | 190001269 | null | null | null | null | 2016-08-20 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100071328 |
| 190006033 | 190001272 | null | null | null | null | 2018-07-05 | Cisplatin | null | null | CISPLATIN | 100971404 |
| 190006034 | 190001273 | 1.59 | 79.6 | Palliative (P) | 2018-08-02 | 2018-08-21 | Carboplatin + Pemetrexed | 02 | N | TRIAL | 100004641 |
| 190006037 | 190001276 | null | 53.8 | Curative (C) | 2018-10-01 | 2018-10-02 | Cisplatin | 02 | N | CISPLATIN | 100900415 |
| 190006044 | 190001278 | null | null | null | null | 2017-08-17 | Cisplatin+Gemcitabine (gallbladder) | null | null | CISPLATIN + GEMCITABINE | 101746898 |
| 190006047 | 190001280 | null | null | null | null | 2016-12-15 | VIDE | null | null | GEMCARBO | 101506808 |
| 190006053 | 190001283 | 1.5 | 55 | Neo-adjuvant (N) | 2018-01-25 | 2018-02-16 | CISPLATIN + GEMCITABINE | 01 | null | CISPLATIN + GEMCITABINE | 101214554 |
| 190006055 | 190001284 | null | null | null | null | 2017-05-19 | CISPLATIN + ETOPOSIDE | null | null | OCTREOTIDE | 100580236 |
| 190006058 | 190001285 | null | null | null | null | 2017-06-29 | Dox + HD Mtx (post PAM) | null | null | DOCETAXEL | 100800819 |
| 190006061 | 190001286 | 1.83 | 87 | null | 2017-02-26 | 2017-02-27 | Cisplatin + Radiotherapy + CISPLATIN | 02 | null | ECX | 100795583 |
| 190006064 | 190001287 | null | null | null | null | 2018-08-30 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 100010129 |
| 190006066 | 190001288 | null | null | null | null | 2018-07-11 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101795287 |
| 190006073 | 190001289 | null | null | null | null | 2018-11-29 | Cisplatin + Radiotherapy | null | null | CISPLATIN + FLUOROURACIL | 100989461 |
| 190006085 | 190001293 | null | null | null | null | 2016-02-24 | Gemcitabine weekly | null | null | SUNITINIB | 100009680 |
| 190006092 | 190001295 | 1.65 | null | Palliative (P) | 2016-04-20 | 2016-04-21 | Dox + HD Mtx (post PAM) | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100998844 |
| 190006094 | 190001296 | 1.56 | 55.8 | Palliative (P) | 2019-09-15 | 2019-09-19 | EW EuroEwing 2012 Arm A VIDE | N | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100188080 |
| 190006098 | 190001297 | 0 | 57 | Palliative (P) | 2017-04-20 | 2017-05-04 | CISPLATIN + RT | 02 | N | CISPLATIN | 100361785 |
| 190006100 | 190001299 | 1.65 | 82 | null | 2019-05-01 | 2019-05-07 | Carboplatin + Paclitaxel (weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101311331 |
| 190006104 | 190001300 | 1.59 | 78.4 | Curative (C) | 2018-12-08 | 2018-12-08 | EURAMOS TRIAL | 02 | N | CISPLATIN + RT | 100541214 |
| 190006110 | 190001302 | 1.77 | 66 | Curative (C) | 2018-06-15 | 2018-06-16 | Dox + HD Mtx (post PAM) | 02 | Y | CAPECITABINE | 101583985 |
| 190006115 | 190001305 | 1.65 | 95 | Curative (C) | 2016-07-13 | 2016-08-03 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100820540 |
| 190006117 | 190001306 | 1.87 | 60 | Neo-adjuvant (N) | 2019-06-05 | 2019-06-14 | Doxorubicin 75mg/m2 | 02 | N | EOX | 101762728 |
| 190006121 | 190001309 | null | null | null | null | 2017-09-16 | CISPLATIN + FLUOROURACIL | null | null | LANREOTIDE | 101029156 |
| 190006127 | 190001311 | null | null | null | null | 2017-02-12 | FCiSt | null | null | CAPECITABINE + OXALIPLATIN | 101674673 |
| 190006130 | 190001314 | 0 | 64.5 | Adjuvant (A) | 2017-11-11 | 2017-12-07 | Irinotecan + Modified De Gramont | 02 | N | DOCETAXEL | 100256710 |
| 190006131 | 190001315 | null | null | null | null | 2017-03-02 | EURAMOS TRIAL | null | null | CISPLATIN + RT | 100863506 |